Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study

Publication | Open Access

DOI Full Paper Access

137

Citations

References

2016

Year

Won Park, Dae‐Hyun Yoo, Janusz Jaworski, Jan Brzezicki, A. Gnylorybov, Vladimir Kadinov, Irmgadt Goecke Sariego, Carlos Abud‐Mendoza, William J. Otero Escalante, Seong Wook Kang,

Arthritis Research & Therapy

Abstract

References